New approach to restore Penicillin's combating power

Image
Press Trust of India Washington
Last Updated : Apr 15 2014 | 5:07 PM IST
A new approach may restore Penicillin's combat effectiveness, even against 'superbugs', by pairing the drug with a protective polymer, scientists say.
"Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections," researchers said.
Now, scientists at the University of South Carolina have reported a new approach to restoring its combat effectiveness, even against so-called superbugs.
Bacteria have been chipping away at the power of the penicillin family of drugs since their first wide-scale use as antibiotics in the 1940s, researchers said.
A cyclic four-membered amide ring termed a beta-lactam is a common structural element of the penicillins, their synthetic and semi-synthetic derivatives.
Physicians heavily use the many versions of beta-lactam antibiotics to fight bacterial infections, and many have been retired because they're no longer effective against the defences bacteria have evolved in response.
One of the most effective bacterial defences is an enzyme called beta-lactamase, which chews up the beta-lactam structure, researchers said.
Some bacteria, such as MRSA, have developed the ability to biosynthesise and release beta-lactamase when needed.
The new approach by Carolina's Chuanbing Tang pairs the drug with a protective polymer developed in his chemistry laboratory.
In lab tests, graduate student Jiuyang Zhang prepared a cobaltocenium metallopolymer that greatly slowed the destructiveness of beta-lactamase on a model beta-lactam molecule (nitrocefin).
The interdisciplinary team also showed that the antimicrobial effectiveness of the four beta-lactams studied in detail was enhanced by the polymer.
The enhancement was modest against two strains, but very pronounced with the hospital-associated strain of MRSA (HA-MRSA).
The metallopolymer by itself even demonstrated antimicrobial properties, lysing bacterial cells while leaving human red blood cells unaffected.
By a variety of measures, the polymer was found to be nontoxic to human cells in laboratory tests.
The research was published in the Journal of the American Chemical Society.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 15 2014 | 5:07 PM IST

Next Story